EMEA-002515-PIP01-18

Table of contents

Key facts

Active substance
Human immunoglobulin G2 isotype antibody to IL-33R
Therapeutic area
Pneumology-allergology
Decision number
P/0055/2020
PIP number
EMEA-002515-PIP01-18
Pharmaceutical form(s)
Powder for solution for injection
Condition(s) / indication(s)
Treatment of asthma
Route(s) of administration
Intravenous use
Contact for public enquiries
GlaxoSmithKline Trading Services Limited

Tel. +44 (0)20 8990 3650
E-mail: eu.paediatric-plans@gsk.com

Decision type
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)

Decision

How useful was this page?

Add your rating